Introducing eScreen
M&K Record Researchers now uses the eScreen eReader for state of the art drug testing results. Please contact us for more information.
The eReader is the premier instrumented point-of-collection testing device for paperless, web-based collections.
The eScreen eReader is the only instrumented point-of-collection drug testing device on the market. Designed to activate the eCup, read the results of the test and transmit those results to the eScreen software suite, for test result reporting to the client.
Advantages to eScreen’s advanced, web-based screening solution for clinics and employers:
Receive drug test information on demand with eScreen’s automated hiring program management application.
Test results 15-minutes after completion for all screened negatives
:: Same day hiring decisions
:: Beat out competitors for the best candidates
:: Post Accident/Injury situations – the employee can be back to work faster
:: Screened negative results comprise 90-99% of all tests
Advanced web-based reporting available through MyeScreen.com
:: Review and print drug test check results
:: Monitor drug test result status
:: eMail Notification of results from a secure Inbox
:: Scheduling Tool and ePassport
:: Generate statistical reports
:: Generate Turnaround Time reports
Certified Collection Network
:: Most comprehensive network of occupational health providers
:: Nationwide testing through the network
:: Over 1,500 clinics installed with the eScreen Drugs of Abuse Testing System
Integrated Solution for Hybrid Programs
:: Lab-based, non-regulated and DOT testing with consistent process and data delivery for ease of implementation and corporate compliance
Integrity of Test Collections
:: Testing is performed under seal in the original collection cup, ensuring the integrity of the test and eliminating human error
Built-in Specimen Validity Profile
:: Automatically detects dilute or adulterated specimens
Automated Test Result Interpretation
:: Electronic interpretation and optical imaging in the eReader eliminates error from human interpretation and provides greater confidentiality of results
A Variety of Result Reporting Options
:: Online via your secure MyeScreen.com account
:: Automated Voice Response (AVR)
:: Electronic Data Transfer
:: Autofax
Electronic Chain of Custody form is automatically generated.
:: Chain of Custody errors are minimized, lessening delays and extra paperwork
Positive results reviewed by an MRO.
:: Verifies proper Chain of Custody
:: Rules out legitimate medical reasons for a positive result
Endorsement by Fortune 1000 companies
:: Many large employers have already committed to the eScreen Drugs of Screening Solution to manage their drug testing program
Validation Study
Evaluation of the eScreen eCup Drugs of Abuse Screening Device: Correlation with EMITII and GC/MS.
The eCup Drugs of Abuse screening system is a urine collection device and immunochromatographic assay. The assay provides a rapid test system with the eScreen eReader to provide qualitative results within 8 minutes or less using SAMHSA cutoff concentrations. eScreen assays for Amphetamine (as Methamphetamine), Cannabinoids (THC), Cocaine Metabolite (as Benzoylecgonine), Opiates (as Morphine), and PCP (Phencyclidine) were evaluated in this study.
Qualitative drug screening results obtained by an independent study of testing clinical samples with eCup Drugs of Abuse Screening Device were compared to qualitative results obtained by EMIT II (Syva, Dade Behring).
All Positive eScreen and EMIT II results were confirmed by GC/MS (Gas Chromatography/Mass Spectrometry).
Results show the eCup Drugs of Abuse Screening Device for the rapid qualitative detection of Amphetamines, Cannabinoids (THC), Cocaine Metabolite, Opiates and PCP can provide accurate and reliable screening results in urine when compared to a SAMHSA laboratory.



